Asset Publisher

New skeletal disease found and explained by CMM researchers

New skeletal disease found and explained by CMM researchers

Researchers from the group Rare Diseases have discovered a new and rare skeletal disease. In a study published in the journal Nature Medicine they describe the molecular mechanism of the disease, in which small RNA molecules play a role that has never before been observed in a congenital human disease.

The study’s lead author Giedre Grigelioniene, physician and associate professor, identified the disease causing mutation in a gene called MIR140 together with Fulya Taylan, assistant professor in the same research group. The gene does not give rise to a protein but to a so-called micro-RNA (miR-140), a small RNA molecule that regulates other genes. The identified mutation knocks out a normal function of the micro-RNA, which is replaced by a different function. The mechanism has never before been described involving small RNAs in human congenital disease.

The study was carried out in collaboration with researchers from, among others, Massachusetts General Hospital and Harvard University in Boston and the Massachusetts Institute of Technology.

 

Giedre Grigelioniene and Fulya Taylan. Photo: Rick Guidotti

 

The study Gain-of-function mutation of microRNA-140 in human skeletal dysplasia was published in the scientific journal Nature Medicine on February 25 2019.

Read more about the study at Karolinska Institutet website.

 

NEWS

Unexpected effect of MS drug

Unexpected effect of MS drug Karl Carlström and Fredrik Piehl Photo: Stefan Zimmerman   Researchers at CMM have studied the mechanism of action of a drug used to treat...

New findings about how Parkinson's disease develops

New findings about how Parkinson's disease develops A new study by researchers at CMM shows that the protein alpha-synuclein, which accumulates in patients with Parkinson’s disease, occurs...

New method divides patients with ulcerative colitis in groups

New method divides patients with ulcerative colitis in groups Researchers at CMM have found a way of using gene expression conserved across species to divide patients with the inflammatory...

Rheumatoid arthritic pain could be caused by antibodies

Rheumatoid arthritic pain could be caused by antibodies In a recently published study, researchers at CMM has shown that antibodies that exist in the joints before the onset of rheumatoid...

Financial support from The Swedish Childhood Cancer Fund to Ann Nordgren for her research position

Financial support from The Swedish Childhood Cancer Fund to Ann Nordgren for her research position Research positions are awarded once a year by the Swedish Childhood Cancer Fund. In 2019,...

Rare disease gives new insight into regulatory T-cell function

Rare disease gives new insight into regulatory T-cell function An international study led by researchers at CMM provides new insights into the regulatory T cells’ role in protecting against...

Antibodies stabilize plaque in arteries

Antibodies stabilize plaque in arteries A recent study, led by researchers at CMM, shows that type IgG antibodies play an unexpected role in atherosclerosis. The researchers hope that...

Prestigious grant for research on autoimmunity

Prestigious grant for research on autoimmunity Professor Olle Kämpe is one of five appointed Wallenberg Clinical Scholars in 2019. He will receive SEK 15 million to study why the immune...

Molecular puzzle reveals unknown stages of fetal development

Molecular puzzle reveals unknown stages of fetal development By applying gene analysis to individual cells from early mouse embryos, CMM researcher Qiaolin Deng and her team have discovered...

New skeletal disease found and explained by CMM researchers

New skeletal disease found and explained by CMM researchers Researchers from the group Rare Diseases have discovered a new and rare skeletal disease. In a study published in the journal...